BC Cancer - Fall 2017 - 14

LEGACY GIVING

Making a Lasting Mark
Brian Moore's legacy gift will help propel immunotherapy
trials at the BC Cancer Agency Vancouver Island Centre

B

rian Moore champions the
importance of giving back to
a world that's brought him so
much in life.
"Those of us lucky enough to have
been born here have won the lottery,"
he says. "We've all been very blessed."
Moore's words of gratitude come in
spite of losing his wife, Rose Marie, to
an aggressive form of cancer just shy
of two years ago, following five years of
chemotherapy and radiation therapy
at the BC Cancer Agency.
It's why they both decided, prior
to her death, to will a portion of their
estate-on top of a $25,000 donation

14

PARTNERS IN DISCOVERY

-to improve cancer research and care
for patients across British Columbia
and beyond.
"She had a really great team over
there and everyone was so incredibly
kind," Brian says.
"She wanted to ensure that
funds were available to help future
generations, to one day be able to find
a cure for cancer."

The Moores chose to direct their
gifts to help fund the groundbreaking
immunotherapy program underway
at the BC Cancer Agency Trev & Joyce
Deeley Research Centre. The program
involves activating and expanding
a patient's own T cells-immune
cells that circulate through the body
searching for diseases to eliminate-
and infuse large numbers of them
back into the bloodstream to fight off
cancer cells.
"It was quite exciting for her to
learn about this treatment and it's
why she was eager to support it, only
unfortunately it came at the end of
her life," Brian says.
Clinical trials for the cutting-edge
treatment are geared to begin this
year for patients with ovarian and
cervical cancers, following promising
results for treating melanoma and
childhood leukemia elsewhere.
It's a significant stride made
possible in part through legacy
giving at the BC Cancer Foundation,
says Dr. Brad Nelson, director of the
Deeley Research Centre.
"Thanks to the generosity of
donors such as Brian, we're able
to make critical advancements in
immunotherapy research and bring
game-changing treatments to patients
across Vancouver Island, the province
and world," he says.
Sarah Roth, President and CEO of
the BC Cancer Foundation, commends
the Moores for their support.
"Brian Moore and BC Cancer
Foundation donors like him are to
be congratulated for their foresight
and generosity, bringing new hope to
the 77,000 British Columbians facing
cancer today."

LEAVE A LEGACY OF CARE
For more information on legacy giving at the BC Cancer
Foundation, visit bccancerfoundation.com/legacy.
http://www.bccancerfoundation.com/legacy
Table of Contents for the Digital Edition of BC Cancer - Fall 2017
